Immunology 

Page 1 of 4
1 2 3 4  >
  • Tiotropium and chronic obstructive pulmonary disease

    Tiotropium is a once daily, inhaled, long acting anticholinergic drug that provides at least 24 hour improvement in airflow and hyperinflation in patients with chronic obstructive pulmonary disease (COPD).

    British Medical Journal (Immunology) - Mon, 22 February 2010
    http://www.bmjjournals.com

  • Management of polymyalgia rheumatica

    Evidence is lacking on the management of polymyalgia rheumatica. The recent guidelines published by the British Society for Rheumatology (BSR) and the British Health Professionals in Rheumatology (BHPR) are a brave attempt to give some structure to the diagnosis and treatment of this condition.

    British Medical Journal (Immunology) - Fri, 5 February 2010
    http://www.bmjjournals.com

  • Thyroid disease in women is linked to non-stick chemicals, study finds

    A raised serum concentration of an industrial chemical known to be toxic in laboratory animals is associated with thyroid disease in the human population in the United Sates, say researchers based at the UK’s Exeter University

    British Medical Journal (Immunology) - Fri, 22 January 2010
    http://www.bmjjournals.com

  • Childhood vaccination and progress towards MDG4

    Agencies and individuals worldwide are continuing their efforts to vaccinate the world's children and their achievements are highlighted by State of the World's Vaccines and Immunization, a major report published recently by WHO, UNICEF, and The World Bank. “We have good news…”, announced Daisy Mafubelu, Assistant Director General of Family and Community Health at WHO (Geneva, Switzerland). “The number of children being vaccinated is now at an all time high—and we have the numbers to prove this.” In 2008, 106 million children received routine vaccinations for childhood killer infectious diseases including measles, whooping cough, tetanus, and polio, more children than have ever been vaccinated in a single year.

    The Lancet Infectious Diseases (Immunology) - Tue, 24 November 2009
    http://www.thelancet.com/journals/laninf

  • Reducing differences in the uptake of immunisations in children and young people aged under 19 years

    Dr Anthony Harnden, GP member of the Joint Committee on Vaccination and Immunisation and co-opted expert to the NICE Public Health Interventions Advisory Committee, talks about new NICE guidance on immunisation

    National Institute for Health and Clinical Excellence (Immunology) - Fri, 16 October 2009
    http://www.nice.org.uk

  • Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome

    Wiskott-Aldrich syndrome (WAS) is a severe X-linked immunodeficiency caused by mutations in the gene encoding for WASP, a key regulator of signaling and cytoskeletal reorganization in hematopoietic cells. Mutations in WASP result in a wide spectrum of clinical manifestations ranging from the relatively mild X-linked thrombocytopenia to the classic full-blown WAS phenotype characterized by thrombocytopenia, immunodeficiency, eczema, and high susceptibility to developing tumors and autoimmune manifestations.

    Blood (Immunology) - Fri, 19 June 2009
    http://www.bloodjournal.org/

  • Global use of rotavirus vaccines recommended

    Rotavirus vaccination should be included in all national immunization programmes to protect children from a virus that kills more than 500 000 children every year, an advisory group of experts has recommended.

    World Health Organization (Immunology) - Fri, 12 June 2009
    http://www.who.int

  • WHO backs anti-diarrhoea vaccine

    The World Health Organization says a vaccine which can prevent a diarrhoea and vomiting virus should be given to all children as a routine vaccination.

    BBC News (Immunology) - Fri, 5 June 2009
    http://news.bbc.co.uk

  • Campaign Aims to Boost Adult Vaccinations

    Decades ago, attaining immunity from infectious diseases was little more than a game of chance. For some, exposure to disease caused severe illness. Others walked away unscathed.

    Journal of the American Medical Association (Immunology) - Fri, 22 May 2009
    http://jama.ama-assn.org/

  • HIV Studies: Progress in Microbicides, Dead End for an Immune-Boosting Strategy

    After years of disappointing attempts to develop a vaginal microbicide that helps protect women from HIV infection, researchers announced preliminary findings from the first trial to show promising results.

    Journal of the American Medical Association (Immunology) - Fri, 10 April 2009
    http://jama.ama-assn.org/

1 2 3 4  >
Page 1 of 4